This means more to this company than anything else. If this shows immunogenicity in humans there will be a fast track to get it through phase 2 and 3. I’m hoping that it does not show any over activity immune response. If this happens the stock will soar once more and all the shorty nay sayers will be gone. Imagine what 2021 will look like with a covid and influenza vaccine hitting the market. If it fails then it’s back where it started only time will tell.
News 
Market Data 
Discover 
AI
